Precision, Gene-Edited Antimicrobial Targets Difficult-to-Treat E. Coli

An oral, gene-edited antimicrobial has shown early promise against a serious food-borne bacterium that particularly affects children and cannot be treated with antibiotics. The post Precision, Gene-Edited Antimicrobial Targets Difficult-to-Treat <i>E. Coli</i> appeared first on Inside Precision Medicine .